Steffen Syrbe

Professor, Consultant Neuropediatrics and Pediatrics, Head of Division for Pediatric Epileptology

Heidelberg University

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Steffen Syrbe is a consultant in Neuropediatrics and Pediatrics and the Head of the Division for Pediatric Epileptology at Heidelberg University, Germany. His research areas include the health-related quality of life in children with epilepsy, treatment of hypophosphatemia in RASopathy, and the genetic underpinnings of early-onset epilepsy syndromes. He has authored various articles addressing the complexity of pediatric neurodevelopmental disorders and innovative clinical trials in the field.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (2)

Johannes Lemke

Leipzig University

GERMANY

View details

Victoria San Antonio‐Arce

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Steffen Syrbe

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Sleep disturbances and health-related quality of life in children with epilepsy: A caregiver survey

Exome sequencing in Nigerian children with early‐onset epilepsy syndromes

Targeted treatment of hypophosphatemia with trametinib in HRAS-related mosaic RASopathy

Amitriptyline use in individuals with KCNQ2/3 gain-of-function variants: A retrospective cohort study

Correlation of endoscopic third ventriculostomy with postoperative body temperature elevation: a single-center retrospective comparative study

De novo variants in RYBP are associated with a severe neurodevelopmental disorder and congenital anomalies

Early mortality in STXBP1-related disorders

KaRhab: an international online registry for cardiac rhabdomyomas

Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months of age (PROTECT), a two-arm, randomized, observer-blind, controlled phase IIb national multicentre clinical trial: study protocol

Novel Digital Anomalies, Hippocampal Atrophy, and Mutations Expand the Genotypic and Phenotypic Spectra of CNKSR2 in the Houge Type of X-Linked Syndromic Intellectual Development Disorder (MRXSHG)

Collaborators (2)

Johannes Lemke

Victoria San Antonio‐Arce

Make your next move.